The treatment of hepatocellular carcinoma with SP94 modified asymmetrical bilayer lipid-encapsulated Cu(DDC)<sub>2</sub> nanoparticles facilitating Cu accumulation in the tumor-Reference-Cited by-同舟云学术

The treatment of hepatocellular carcinoma with SP94 modified asymmetrical bilayer lipid-encapsulated Cu(DDC)₂ nanoparticles facilitating Cu accumulation in the tumor

Published:2022-12-09 Issue:1 Volume:20 Page:145-158
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Liu Hao¹,Kong Yihan²,Liang Xue³,Liu Zixu¹,Guo Xueting¹,Yang Bing⁴,Yin Tian⁵,He Haibing¹,Gou Jingxin¹,Zhang Yu¹^ORCID,Tang Xing¹

Affiliation:

1. Department of Pharmaceutics Science, Shenyang Pharmaceutical University, Shenyang, China

2. Technology Research & Development Centre, Tianjin Pharmaceutical Research Institute Co., Ltd, Tianjin, China

3. R&D & Innovation Committee, CSPC Pharmaceutical Group Limited, Shijiazhuang, China

4. Department of Traditional Chinese Medicine, Shenyang Pharmaceutical University, Shenyang, China

5. Department of Functional Food and Wine, Shenyang Pharmaceutical University, Shenyang, China

Funder

National Natural Science Foundation of China

National Key R&D Program of China

Liaoning Revitalization Talents Program

Liaoning Province Doctoral Start-up Fund Program

Development Program for Young and Middle-aged Teachers of Shenyang Pharmaceutical University

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2023.2155631

Reference45 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

3. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods

4. Hepatocellular carcinoma

5. Epidemiology and surveillance for hepatocellular carcinoma: New trends

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SP94 engineered erythrocyte membrane enhanced the targeted delivery of biomimetic nanosuspension with IDO immunotherapy and chemotherapy in liver cancer;Chemical Engineering Journal;2024-07

2. Nanomedicine-based disulfiram and metal ion co-delivery strategies for cancer treatment;International Journal of Pharmaceutics: X;2024-06

3. Activate the endogenous Cu2+ switch for Zn(DDC)2 liposomes conversion: Providing a safer and less toxic alternative in cancer therapy;International Journal of Pharmaceutics;2024-03

4. The self-adjuvant heterocyclic lipid nanoparticles encapsulated with vaccine and STAT3 siRNA boost cancer immunotherapy through DLN-targeted and STING pathway;Chemical Engineering Journal;2023-11

5. Dual-responsive PEG–lipid polyester nanoparticles for siRNA and vaccine delivery elicit anti-cancer immune responses by modulating tumor microenvironment;Biomaterials Science;2023